Literature DB >> 16740557

Effectiveness of antibiotics given before admission in reducing mortality from meningococcal disease: systematic review.

Susan J M Hahné1, André Charlett, Bernadette Purcell, Susanne Samuelsson, Ivonne Camaroni, Ingrid Ehrhard, Sigrid Heuberger, Maria Santamaria, James M Stuart.   

Abstract

OBJECTIVE: To review the evidence for effectiveness of treatment with antibiotics before admission in reducing case fatality from meningococcal disease.
DESIGN: Systematic review. DATA SOURCES: Cochrane register of trials and systematic reviews, database of abstracts of reviews of effectiveness, health technology assessment, and national research register in England and Wales, Medline, Embase, and CAB Health. INCLUDED STUDIES: Studies describing vital outcome of at least 10 cases of meningococcal disease classified by whether or not antibiotics were given before admission to hospital.
RESULTS: 14 observational studies met the review criteria. Oral antibiotic treatment given before admission was associated with reduced mortality among cases (combined risk ratio 0.17, 95% confidence interval 0.07 to 0.44). In seven studies in which all included patients were seen in primary care, the association between parenteral antibiotics before admission and outcome was inconsistent (chi2 for heterogeneity 11.02, P = 0.09). After adjustment for the proportion given parenteral antibiotics before admission, there was no residual heterogeneity. A higher proportion of patients given parenteral antibiotics before admission was associated with reduced mortality after such treatment and vice versa (P = 0.04).
CONCLUSION: Confounding by severity is the most likely explanation both for the beneficial effect of oral antibiotics and the harmful effect observed in some studies of parenteral antibiotics. We cannot conclude whether or not antibiotics given before admission have an effect on case fatality. The data are consistent with benefit when a substantial proportion of cases are treated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740557      PMCID: PMC1473099          DOI: 10.1136/bmj.332.7553.1299

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  28 in total

1.  Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group.

Authors:  N Barquet; P Domingo; J A Caylà; J González; C Rodrigo; P Fernández-Viladrich; F A Moraga-Llop; F Marco; J Vázquez; J A Sáez-Nieto; J Casal; J Canela; M Foz
Journal:  JAMA       Date:  1997-08-13       Impact factor: 56.272

2.  Outcome of pre-hospital antibiotic treatment of meningococcal disease.

Authors:  H T Sørensen; G L Nielsen; H C Schønheyder; F H Steffensen; I Hansen; S Sabroe; J F Dahlerup; H Hamburger; J Olsen
Journal:  J Clin Epidemiol       Date:  1998-09       Impact factor: 6.437

3.  Optimising the investigation of meningococcal disease.

Authors:  K Cartwright; S Kroll
Journal:  BMJ       Date:  1997-09-27

4.  875 cases of bacterial meningitis: diagnostic procedures and the impact of preadmission antibiotic therapy. Part III of a three-part series.

Authors:  V Bohr; N Rasmussen; B Hansen; H Kjersem; O Jessen; N Johnsen; H S Kristensen
Journal:  J Infect       Date:  1983-11       Impact factor: 6.072

5.  [An analysis of prior antibiotic treatment on the impact of meningococcal disease in children of the Valencian Community. The Study Group of Invasive Diseases].

Authors:  A Morant Gimeno; J Díez Domingo; C Gimeno Cardona; I Pereiró Berenguer; J Brines Solanes; V Saurí Martí
Journal:  An Esp Pediatr       Date:  1999-01

6.  Pre-hospital parenteral antibiotic treatment of meningococcal disease and case fatality: a Danish population-based cohort study.

Authors:  B Nørgård; H T Sørensen; E S Jensen; T Faber; H C Schønheyder; G L Nielsen
Journal:  J Infect       Date:  2002-10       Impact factor: 6.072

Review 7.  Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review.

Authors:  Bernadette Purcell; Susanne Samuelsson; Susan J M Hahné; Ingrid Ehrhard; Sigrid Heuberger; Ivonne Camaroni; André Charlett; James M Stuart
Journal:  BMJ       Date:  2004-06-05

8.  Case fatality of meningococcal disease in western Norway.

Authors:  A Halstensen; S H Pedersen; B Haneberg; B Bjorvatn; C O Solberg
Journal:  Scand J Infect Dis       Date:  1987

9.  Epidemiology of meningococcal disease and a community outbreak in Somerset.

Authors:  D J Gunnell; N Pearson; B Ley; A Hill
Journal:  Commun Dis Rep CDR Rev       Date:  1994-08-19

10.  Parenteral penicillin for children with meningococcal disease before hospital admission: case-control study.

Authors:  Anthony Harnden; Nelly Ninis; Matthew Thompson; Rafael Perera; Michael Levin; David Mant; Richard Mayon-White
Journal:  BMJ       Date:  2006-03-22
View more
  9 in total

1.  Parenteral penicillin before admission to hospital for meningitis.

Authors:  Duncan Keeley
Journal:  BMJ       Date:  2006-06-03

Review 2.  Pre-admission antibiotics for suspected cases of meningococcal disease.

Authors:  Thambu D Sudarsanam; Priscilla Rupali; Prathap Tharyan; Ooriapadickal Cherian Abraham; Kurien Thomas
Journal:  Cochrane Database Syst Rev       Date:  2017-06-14

Review 3.  Invasive meningococcal disease in the 21st century—an update for the clinician.

Authors:  Rachel Dwilow; Sergio Fanella
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

4.  Prevalence, Characteristics, and Determinants of Suboptimal Care in the Initial Management of Community-Onset Severe Bacterial Infections in Children.

Authors:  Fleur Lorton; Martin Chalumeau; Alain Martinot; Rémy Assathiany; Jean-Michel Roué; Pierre Bourgoin; Julie Chantreuil; Gérald Boussicault; Théophile Gaillot; Jean-Pascal Saulnier; Jocelyne Caillon; Christèle Gras-Le Guen; Elise Launay
Journal:  JAMA Netw Open       Date:  2022-06-01

Review 5.  Acute headache.

Authors:  Raeburn B Forbes
Journal:  Ulster Med J       Date:  2014-01

6.  Longer than 2 hours to antibiotics is associated with doubling of mortality in a multinational community-acquired bacterial meningitis cohort.

Authors:  Damon P Eisen; Elizabeth Hamilton; Jacob Bodilsen; Rasmus Køster-Rasmussen; Alexander J Stockdale; James Miner; Henrik Nielsen; Olga Dzupova; Varun Sethi; Rachel K Copson; Miriam Harings; Oyelola A Adegboye
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.379

7.  Improvements in the outcome of children with meningococcal disease.

Authors:  Fauzia Paize; Stephen D Playfor
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

8.  Pre-hospital antibiotic treatment and mortality caused by invasive meningococcal disease, adjusting for indication bias.

Authors:  Emilio Perea-Milla; Julián Olalla; Emilio Sánchez-Cantalejo; Francisco Martos; Petra Matute-Cruz; Guadalupe Carmona-López; Yolanda Fornieles; Aurelio Cayuela; Javier García-Alegría
Journal:  BMC Public Health       Date:  2009-04-03       Impact factor: 3.295

Review 9.  Care of the patient with invasive meningococcal disease by prehospital emergency medical service clinicians: a scoping review.

Authors:  James Pearce; Micah Peters; Nikki May; Helen Marshall; Cindy Hein; Hugh Grantham
Journal:  BMJ Open       Date:  2020-02-28       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.